Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
bioMerieux SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 7
bioMerieux SA, Medical Equipment Deals By Type, 2012 to YTD 2018 8
bioMerieux SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 9
bioMerieux SA, Medical Equipment, Deals By Market, 2012 to YTD 2018 10
bioMerieux SA, Medical Equipment, Deals Summary, 2012 to YTD 2018 11
bioMerieux SA, Medical Equipment, Deal Details 13
Venture Financing 13
Qvella Raises USD20 Million in Series B Financing 13
Astute Medical Raises Additional USD1 Million in Venture Financing 15
Astute Medical Raises USD2 Million in Venture Financing 16
Astute Medical Raises USD20 Million in Venture Financing 17
Astute Medical Secures USD40 Million in Venture Funding from CRG (Capital Royalty) 18
Astute Medical Raises USD20 Million in Venture Financing 19
Quanterix Raises US$19 Million In Series C Financing 20
BioFire Diagnostics Raises USD25 Million in Financing Round 22
Astute Medical Raises US$40.4 Million In Series C Financing 23
Astute Medical Raises US$2 Million In Venture Financing 25
Private Equity 26
BioTheranostics Raises USD32 Million in Private Equity Financing 26
Athyrium Opportunities Fund Invests US$20 Million In BioFire Diagnostics 27
Partnerships 28
Quanterix Enters into Licensing Agreement with bioMerieux 28
BioMerieux Enters into Licensing Agreement with Astute Medical 29
Seegene Enters Into Licensing Agreement With BioMerieux For DPO And TOCE Technologies 30
Lonza Walkersville Enters Into Licensing Agreement With Hyglos For Endotoxin Detection Patents 31
bioMerieux Enters Into Licensing Agreement With Quanterix For Simoa Technology 32
Astute Medical Enters into Distribution Agreement with bioMerieux 33
Biomerieux Enters into Agreement with Banyan Biomarkers 34
ITL Biomedical Enters into Distribution Agreement with bioMerieux Canada 35
Biotheranostics Enters into Agreement with Syapse 36
BioMerieux Enters into Co-Development Agreement with Copan Italia 37
BioMerieux Enters into Distribution Agreement with Copan 38
Astute Medical Enters into Distribution Agreement with Fosun Long March 39
BioMerieux Enters into Distribution Agreement with Copan for WASP and WASPLab 40
BioMerieux Enters into Co-Development Agreement with Illumina 41
Astute Medical Expands its Co-Marketing Agreement with Ortho-Clinical Diagnostics 42
PathoGenetix And Applied Maths Enter Into Technology Integration Agreement For Pathogen Strain Typing 43
OpGen Enters Into Agreement With Applied Maths To Develop Whole Genome Mapping Software 44
Thermo Fisher Scientific Extends Co-Development Agreement With bioMerieux For Procalcitonin Testing 45
Equity Offering 46
Astute Medical Raises USD43 Million in Private Palcement of Shares 46
Debt Offering 47
bioMerieux Completes Private Placement Of Bonds Due 2020 For US$406.6 Million 47
Acquisition 48
bioMerieux Acquires Astute Medical for USD90 Million 48
bioMerieux to Acquire 34% Stake in Sysmex bioMerieux from Sysmex 49
BioMerieux Acquires Applied Maths 50
BioMerieux Completes Acquisition Of BioFire Diagnostics For US$486 Million 51
bioMerieux SA – Key Competitors 53
bioMerieux SA – Key Employees 54
bioMerieux SA – Locations And Subsidiaries 56
Head Office 56
Other Locations & Subsidiaries 56
Recent Developments 60
Financial Announcements 60
Apr 19, 2018: biomerieux – First-quarter 2018 Business Review 60
Jan 23, 2018: bioMerieux – Fourth-Quarter 2017 Business Review 62
Aug 30, 2017: bioMerieux – First-Half 2017 Results 65
Jul 20, 2017: bioMerieux – Second-Quarter 2017 Business Review 68
Apr 20, 2017: bioMerieux – First-Quarter 2017 Business Review 70
Mar 01, 2017: bioMerieux – 2016 Financial Results 73
Jan 19, 2017: bioMerieux – Fourth-Quarter 2016 Business Review 76
Corporate Communications 78
Apr 23, 2018: bioMerieux and the University of Antwerp award scholarships to three healthcare professionals for their commitment to improve antibiotic use in order to combat antimicrobial resistance 78
Product News 79
Jan 05, 2017: Quanterix to Present at The 35th Annual J.P. Morgan Healthcare Conference 79
Other Significant Developments 80
Oct 18, 2017: bioMerieux – Business review for the nine months ended September 30, 2017 80
Appendix 82
Methodology 82
About GlobalData 82
Contact Us 82
Disclaimer 82
bioMerieux SA, Medical Equipment, Key Facts, 2017 2
bioMerieux SA, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
bioMerieux SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 7
bioMerieux SA, Medical Equipment Deals By Type, 2012 to YTD 2018 8
bioMerieux SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 9
bioMerieux SA, Deals By Market, 2012 to YTD 2018 10
bioMerieux SA, Medical Equipment, Deals Summary, 2012 to YTD 2018 11
Qvella Raises USD20 Million in Series B Financing 13
Astute Medical Raises Additional USD1 Million in Venture Financing 15
Astute Medical Raises USD2 Million in Venture Financing 16
Astute Medical Raises USD20 Million in Venture Financing 17
Astute Medical Secures USD40 Million in Venture Funding from CRG (Capital Royalty) 18
Astute Medical Raises USD20 Million in Venture Financing 19
Quanterix Raises US$19 Million In Series C Financing 20
BioFire Diagnostics Raises USD25 Million in Financing Round 22
Astute Medical Raises US$40.4 Million In Series C Financing 23
Astute Medical Raises US$2 Million In Venture Financing 25
BioTheranostics Raises USD32 Million in Private Equity Financing 26
Athyrium Opportunities Fund Invests US$20 Million In BioFire Diagnostics 27
Quanterix Enters into Licensing Agreement with bioMerieux 28
BioMerieux Enters into Licensing Agreement with Astute Medical 29
Seegene Enters Into Licensing Agreement With BioMerieux For DPO And TOCE Technologies 30
Lonza Walkersville Enters Into Licensing Agreement With Hyglos For Endotoxin Detection Patents 31
bioMerieux Enters Into Licensing Agreement With Quanterix For Simoa Technology 32
Astute Medical Enters into Distribution Agreement with bioMerieux 33
Biomerieux Enters into Agreement with Banyan Biomarkers 34
ITL Biomedical Enters into Distribution Agreement with bioMerieux Canada 35
Biotheranostics Enters into Agreement with Syapse 36
BioMerieux Enters into Co-Development Agreement with Copan Italia 37
BioMerieux Enters into Distribution Agreement with Copan 38
Astute Medical Enters into Distribution Agreement with Fosun Long March 39
BioMerieux Enters into Distribution Agreement with Copan for WASP and WASPLab 40
BioMerieux Enters into Co-Development Agreement with Illumina 41
Astute Medical Expands its Co-Marketing Agreement with Ortho-Clinical Diagnostics 42
PathoGenetix And Applied Maths Enter Into Technology Integration Agreement For Pathogen Strain Typing 43
OpGen Enters Into Agreement With Applied Maths To Develop Whole Genome Mapping Software 44
Thermo Fisher Scientific Extends Co-Development Agreement With bioMerieux For Procalcitonin Testing 45
Astute Medical Raises USD43 Million in Private Palcement of Shares 46
bioMerieux Completes Private Placement Of Bonds Due 2020 For US$406.6 Million 47
bioMerieux Acquires Astute Medical for USD90 Million 48
bioMerieux to Acquire 34% Stake in Sysmex bioMerieux from Sysmex 49
BioMerieux Acquires Applied Maths 50
BioMerieux Completes Acquisition Of BioFire Diagnostics For US$486 Million 51
bioMerieux SA, Key Competitors 53
bioMerieux SA, Key Employees 54
bioMerieux SA, Subsidiaries 56
List of Figures
bioMerieux SA, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
bioMerieux SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
bioMerieux SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
bioMerieux SA, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
bioMerieux SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 7
bioMerieux SA, Medical Equipment, Deals by Type, 2012 to YTD 2018 8
bioMerieux SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 9
bioMerieux SA, Medical Equipment, Deals by Market, 2012 to YTD 2018 10
【免責事項】
http://www.globalresearch.jp/disclaimer